Jones Financial Companies Lllp Sells 123,855 Shares of CVS Health Corporation $CVS

Jones Financial Companies Lllp decreased its holdings in shares of CVS Health Corporation (NYSE:CVS - Free Report) by 85.4% during the first quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 21,156 shares of the pharmacy operator's stock after selling 123,855 shares during the quarter. Jones Financial Companies Lllp's holdings in CVS Health were worth $1,433,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

A number of other hedge funds and other institutional investors have also bought and sold shares of CVS. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. raised its holdings in CVS Health by 34.2% during the 4th quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. now owns 340,269 shares of the pharmacy operator's stock valued at $15,275,000 after acquiring an additional 86,715 shares during the period. Quadcap Wealth Management LLC raised its holdings in CVS Health by 17.1% during the 4th quarter. Quadcap Wealth Management LLC now owns 9,417 shares of the pharmacy operator's stock valued at $423,000 after acquiring an additional 1,374 shares during the period. ProShare Advisors LLC raised its holdings in CVS Health by 13.0% during the 4th quarter. ProShare Advisors LLC now owns 225,757 shares of the pharmacy operator's stock valued at $10,134,000 after acquiring an additional 26,054 shares during the period. Raiffeisen Bank International AG bought a new stake in CVS Health during the 4th quarter valued at $377,000. Finally, Rafferty Asset Management LLC grew its position in shares of CVS Health by 11.9% during the 4th quarter. Rafferty Asset Management LLC now owns 142,717 shares of the pharmacy operator's stock valued at $6,407,000 after purchasing an additional 15,126 shares in the last quarter. Institutional investors own 80.66% of the company's stock.

CVS Health Stock Performance

NYSE CVS opened at $75.00 on Friday. The company has a 50-day simple moving average of $67.11 and a two-hundred day simple moving average of $66.30. The company has a quick ratio of 0.62, a current ratio of 0.80 and a debt-to-equity ratio of 0.74. CVS Health Corporation has a 12-month low of $43.56 and a 12-month high of $75.55. The firm has a market cap of $95.12 billion, a price-to-earnings ratio of 20.95, a PEG ratio of 0.82 and a beta of 0.62.

CVS Health (NYSE:CVS - Get Free Report) last posted its quarterly earnings results on Thursday, July 31st. The pharmacy operator reported $1.81 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.46 by $0.35. CVS Health had a net margin of 1.17% and a return on equity of 10.51%. The business had revenue of $98.92 billion during the quarter, compared to analyst estimates of $94.87 billion. During the same period in the prior year, the business posted $1.83 earnings per share. The company's revenue was up 8.4% on a year-over-year basis. CVS Health has set its FY 2025 guidance at 6.300-6.400 EPS. On average, equities analysts forecast that CVS Health Corporation will post 5.89 EPS for the current year.

CVS Health Dividend Announcement

The firm also recently declared a quarterly dividend, which was paid on Friday, August 1st. Shareholders of record on Tuesday, July 22nd were given a dividend of $0.665 per share. This represents a $2.66 annualized dividend and a yield of 3.5%. The ex-dividend date was Tuesday, July 22nd. CVS Health's dividend payout ratio is presently 74.30%.

Insider Transactions at CVS Health

In other CVS Health news, Director Anne A. Finucane sold 7,500 shares of the company's stock in a transaction dated Wednesday, August 20th. The shares were sold at an average price of $71.02, for a total transaction of $532,650.00. Following the completion of the sale, the director directly owned 22,156 shares in the company, valued at $1,573,519.12. This represents a 25.29% decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which is available at this hyperlink. 1.22% of the stock is currently owned by insiders.

Analyst Ratings Changes

A number of research firms have recently commented on CVS. Baird R W upgraded shares of CVS Health from a "hold" rating to a "strong-buy" rating in a research report on Thursday, August 14th. Sanford C. Bernstein boosted their price target on shares of CVS Health from $72.00 to $77.00 and gave the company a "market perform" rating in a research report on Friday, September 5th. Bernstein Bank reduced their price target on shares of CVS Health from $78.00 to $72.00 and set a "market perform" rating for the company in a research report on Wednesday, July 16th. UBS Group upgraded shares of CVS Health from a "neutral" rating to a "buy" rating and boosted their price target for the company from $67.00 to $79.00 in a research report on Monday, August 18th. Finally, Zacks Research lowered shares of CVS Health from a "strong-buy" rating to a "hold" rating in a research report on Monday, September 8th. Two equities research analysts have rated the stock with a Strong Buy rating, nineteen have issued a Buy rating and three have assigned a Hold rating to the company. According to MarketBeat, CVS Health currently has a consensus rating of "Moderate Buy" and a consensus target price of $77.89.

About CVS Health

CVS Health Corporation provides health solutions in the United States. It operates through Health Care Benefits, Health Services, and Pharmacy & Consumer Wellness segments. The Health Care Benefits segment offers traditional, voluntary, and consumer-directed health insurance products and related services.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.